Skip to main content

Table 4 Comparing groups of patients with normal and elevated uric acid levels

From: Correlation between serum uric acid and pulmonary arterial hypertension based on echo probability in patients with obstructive sleep apnea syndrome

 

Total (n = 100)

Uric acid

Test of sig

p

Normal (n = 26)

Elevated (n = 74)

No

%

No

%

No

%

Sex

 Male

66

66.0

22

84.6

44

59.5

χ2 = 5.426*

0.020*

 Female

34

34.0

4

15.4

30

40.5

Age (years)

 Min.–max

33.0–70.0

33.0–65.0

36.0–70.0

t = 2.464*

0.015*

 Mean ± SD

53.04 ± 8.45

49.62 ± 8.66

54.24 ± 8.09

 Median (IQR)

53.0 (49.0–58.0)

53.0 (45.0–55.0)

54.0 (50.0–60.0)

BMI

 Overweight

6

6.0

6

23.1

0

0.0

χ2 = 15.601*

MC p < 0.001*

 Obese

90

90.0

20

76.9

70

94.6

 Morbid obese

4

4.0

0

0.0

4

5.4

 Min.–max

25.50–40.96

25.50–38.10

30.44–40.96

t = 4.974*

 < 0.001*

 Mean ± SD

34.69 ± 3.10

31.99 ± 3.48

35.64 ± 2.31

 Median (IQR)

35.43 (32.4–36.76)

31.20 (30.60–34.8)

35.99(34.2–36.9)

ESS

 Normal (≤ 10)

6

6.0

2

7.7

4

5.4

χ2 = 0.178

FEp = 0.649

 Abnormal (> 10)

94

94.0

24

92.3

70

94.6

Min.–max

10.0–20.0

10.0–20.0

10.0–20.0

t = 0.705

0.485

Mean ± SD

13.90 ± 2.62

13.54 ± 3.24

14.03 ± 2.37

Median (IQR)

14.0 (12.0–16.0)

12.0 (11.0–15.0)

14.0 (12.0–16.0)

  1. IQR Interquartile range, SD Standard deviation, t Student t-test, χ2 chi-square test, MC Monte Carlo, FE Fisher exact, p p-value for comparing between different categories
  2. *Statistically significant at p ≤ 0.05